MBCL-22. EFFICACY OF DOUBLE-CONDITIONING REGIMEN COMPRISING THIOTEPA AND MELPHALAN FOR RELAPSED MEDULLOBLASTOMA – A SINGLE INSTITUTION EXPERIENCE

BACKGROUND: The prognosis of relapsed medulloblastoma was dismal. Recently, we published the promising outcome of metastatic medulloblastomas treated with a double-conditioning regimen comprising high-dose thiotepa and melphalan (HD-TM). Here, we report a single-center study of HD-TM for relapsed me...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Yamasaki, Kai, Tanimura, Kazuki, Okuhiro, Yuki, Hira, Kota, Nitani, Chika, Okada, Keiko, Fujisaki, Hiroyuki, Kunihiro, Noritsugu, Matsusaka, Yasuhiro, Sakamoto, Hiroaki, Hara, Junichi
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Medulloblastoma (Clinical)
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715182/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.498
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars